[
  {
    "ts": null,
    "headline": "Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion",
    "summary": "Merck (NYSE:MRK) announced the opening of a new $1 billion vaccine manufacturing facility in Durham, North Carolina, a major development aligning with the company's broader $12 billion U.S. investment initiative. This expansion could have played a pivotal role in the 9% rise in the company's share price last month, particularly as it underscores Merck's commitment to innovation and growth. The company's strategic focus on advanced technologies may also position it favorably in a volatile...",
    "url": "https://finnhub.io/api/news?id=dc2fa85348670b7d7d0e729ac9a809f1802e69d0b9c4d7157d4f21dc5b170123",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741715235,
      "headline": "Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion",
      "id": 133184629,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (NYSE:MRK) announced the opening of a new $1 billion vaccine manufacturing facility in Durham, North Carolina, a major development aligning with the company's broader $12 billion U.S. investment initiative. This expansion could have played a pivotal role in the 9% rise in the company's share price last month, particularly as it underscores Merck's commitment to innovation and growth. The company's strategic focus on advanced technologies may also position it favorably in a volatile...",
      "url": "https://finnhub.io/api/news?id=dc2fa85348670b7d7d0e729ac9a809f1802e69d0b9c4d7157d4f21dc5b170123"
    }
  },
  {
    "ts": null,
    "headline": "Merck prevails in Gardasil safety litigation",
    "summary": "A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision...",
    "url": "https://finnhub.io/api/news?id=1de2d9a8a25ef68ec7d918bbdc950889ca1728c0e27b36fbb8226fc25f2712a2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741711219,
      "headline": "Merck prevails in Gardasil safety litigation",
      "id": 133139364,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision...",
      "url": "https://finnhub.io/api/news?id=1de2d9a8a25ef68ec7d918bbdc950889ca1728c0e27b36fbb8226fc25f2712a2"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom",
    "summary": "Molson Coors, Merck & Co. and Deutsche Telekom are part of the Zacks Investment Ideas article.",
    "url": "https://finnhub.io/api/news?id=c1ef27ffcb98c6dea0fd507c0c274b0f9ee18aab6a5e900c4d99224b07e08c85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741701180,
      "headline": "Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom",
      "id": 133184630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Molson Coors, Merck & Co. and Deutsche Telekom are part of the Zacks Investment Ideas article.",
      "url": "https://finnhub.io/api/news?id=c1ef27ffcb98c6dea0fd507c0c274b0f9ee18aab6a5e900c4d99224b07e08c85"
    }
  },
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK",
    "summary": "NEW YORK, March 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc.  . Such investors are advised to contact Danielle Peyton at...",
    "url": "https://finnhub.io/api/news?id=79fec495d53dc46f6262e6bc89bb1fc11de25000fc46c03fe48203fcf9d2a9e3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741700534,
      "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK",
      "id": 133136168,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc.  . Such investors are advised to contact Danielle Peyton at...",
      "url": "https://finnhub.io/api/news?id=79fec495d53dc46f6262e6bc89bb1fc11de25000fc46c03fe48203fcf9d2a9e3"
    }
  },
  {
    "ts": null,
    "headline": "BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund",
    "summary": "BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=0a90bbc72c21544b52437a24252fdcd27158f61d0b5128e17ea6b2ed0058f641",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741698125,
      "headline": "BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund",
      "id": 133136036,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148098716/image_2148098716.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=0a90bbc72c21544b52437a24252fdcd27158f61d0b5128e17ea6b2ed0058f641"
    }
  },
  {
    "ts": null,
    "headline": "Merck Unveils New Facility to Increase Vaccine Production Capacity",
    "summary": "DURHAM, N.C., March 11, 2025--Merck Unveils New Facility to Increase Vaccine Production Capacity",
    "url": "https://finnhub.io/api/news?id=9f7087510b665f7ea06a8e31a75e7583e15887315835c208a08801988f6deb92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741689900,
      "headline": "Merck Unveils New Facility to Increase Vaccine Production Capacity",
      "id": 133184631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "DURHAM, N.C., March 11, 2025--Merck Unveils New Facility to Increase Vaccine Production Capacity",
      "url": "https://finnhub.io/api/news?id=9f7087510b665f7ea06a8e31a75e7583e15887315835c208a08801988f6deb92"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now",
    "summary": "We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other oversold blue chip stocks. The uncertainty related to the tariff announcements continues to influence Wall Street. Reuters reported that […]",
    "url": "https://finnhub.io/api/news?id=a16b5d69bc2ae1bac5da7c05d35e4fd5f791ab9c4df0631a0c1d4363428d6e39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741681341,
      "headline": "Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now",
      "id": 133184632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other oversold blue chip stocks. The uncertainty related to the tariff announcements continues to influence Wall Street. Reuters reported that […]",
      "url": "https://finnhub.io/api/news?id=a16b5d69bc2ae1bac5da7c05d35e4fd5f791ab9c4df0631a0c1d4363428d6e39"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside",
    "summary": "Imagine yourself as a passive income investor looking for a medical stock with significant share growth potential. Wall Street analysts with JP Morgan, Citi, and Evercore ISI would recommend looking at Merck & Co (NYSE: MRK), which they've all given a ...",
    "url": "https://finnhub.io/api/news?id=01c1e4d8fe8749c81bbd066ea693971cb3da123ee296a2e24abfd9b406646ef6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741658442,
      "headline": "Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside",
      "id": 133184633,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Imagine yourself as a passive income investor looking for a medical stock with significant share growth potential. Wall Street analysts with JP Morgan, Citi, and Evercore ISI would recommend looking at Merck & Co (NYSE: MRK), which they've all given a ...",
      "url": "https://finnhub.io/api/news?id=01c1e4d8fe8749c81bbd066ea693971cb3da123ee296a2e24abfd9b406646ef6"
    }
  }
]